Company news
Jade Biosciences, Inc. news in 2022
Jade Biosciences, Inc.'s news releases, calls and decks from 2022, newest first.
Aerovate Therapeutics Publishes Results of Phase 1 Study Evaluating AV-101 for the Treatment of Pulmonary Arterial Hypertension in ERJ Open Research
November 16, 2022
Aerovate Therapeutics Announces Third Quarter 2022 Financial Results
November 13, 2022
Aerovate Therapeutics Presents Novel Phase 2b/Phase 3 IMPAHCT Trial Design at CHEST Annual Meeting 2022
October 17, 2022
Aerovate Therapeutics Announces Second Quarter 2022 Financial Results
August 14, 2022
Aerovate Therapeutics Presents Phase 1 Data for AV-101, A Novel Dry Powder Inhaled Formulation of Imatinib Being Developed for the Treatment of Patients with Pulmonary Arterial Hypertension (PAH)
May 15, 2022
Aerovate Therapeutics Announces First Quarter 2022 Financial Results
May 15, 2022
Aerovate Therapeutics Announces Full-Year 2021 Financial Results
March 29, 2022
Aerovate Therapeutics to Present at Cowen 42nd Annual Health Care Conference
March 1, 2022